30 October 2018 - Four pharmacy benefit managers must face a lawsuit alleging they breached their duties as administrators of employee health insurance plans’ drug benefits by causing Mylan to raise the EpiPen allergy medication’s price, a federal judge has ruled.
U.S. District Judge Paul Magnuson in St. Paul, Minnesota on Friday denied motions by CVS Health, Express Scripts, UnitedHealth and Prime Therapeutics to dismiss a proposed class action by participants in employee health insurance plans.